Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical impact of genetic alterations including germline DDX41mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens

Autor: Sébert, Marie, Freiman, Lucie, Chaffaut, Cendrine, Guerci, Agnès, Peterlin, Pierre, Thépot, Sylvain, Beyne-Rauzy, Odile, Park, Sophie, Cluzeau, Thomas, Chermat, Fatiha, Fenaux, Pierre, Preudhomme, Claude, Clappier, Emmanuelle, Chevret, Sylvie, Adès, Lionel, Duployez, Nicolas, Duchmann, Matthieu

Publikováno v: Leukemia; April 2024, Vol. 38 Issue: 4 p918-922, 5p

Characteristics of Germline CHEK2 Mutated Patients in a Large Cohort of 2322 Myeloid Malignancies

Autor: Freiman, Lucie ^*, Larcher, Lise ^*, Tueur, Giulia ^*, Vasquez, Nadia ^*, Da Costa, Mélanie ^*, Raffoux, Emmanuel ^*, Ades, Lionel, Fenaux, Pierre, Soulier, Jean, Clappier, Emmanuelle ^*, Itzykson, Raphael

Publikováno v: In Blood 15 November 2022 140 Supplement 1:4082-4083

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens.

Autor: Sébert M; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France. marie.sebert@aphp.fr.; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France. marie.sebert@aphp.fr.; Groupe Francophone des Myelodysplasies, Paris, France. marie.sebert@aphp.fr., Freiman L; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France., Chaffaut C; Biostatistics Department, Saint Louis Hospital, AP-HP, Paris, France., Guerci A; Groupe Francophone des Myelodysplasies, Paris, France.; Hematology Department, CHU Brabois Vandoeuvre, Nancy, France., Peterlin P; Groupe Francophone des Myelodysplasies, Paris, France.; Hematology Department, Nantes University Hospital, Nantes, France., Thépot S; Groupe Francophone des Myelodysplasies, Paris, France.; Hematology Department, Angers University Hospital, Angers, France., Beyne-Rauzy O; Groupe Francophone des Myelodysplasies, Paris, France.; Hematology Department, CHU de Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Park S; Groupe Francophone des Myelodysplasies, Paris, France.; Hematology Department, Grenoble University Hospital, Grenoble, France., Cluzeau T; Groupe Francophone des Myelodysplasies, Paris, France.; Hematology Department, Nice University Hospital, Nice, France., Chermat F; Groupe Francophone des Myelodysplasies, Paris, France., Fenaux P; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France.; Groupe Francophone des Myelodysplasies, Paris, France., Preudhomme C; Hematology Laboratory, Unité 1277-Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Lille, France., Clappier E; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.; Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Chevret S; Biostatistics Department, Saint Louis Hospital, AP-HP, Paris, France., Adès L; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.; Hematology Department, Saint Louis Hospital, AP-HP, Paris, France.; Groupe Francophone des Myelodysplasies, Paris, France., Duployez N; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France.; Hematology Laboratory, Unité 1277-Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Lille, France.; Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Duchmann M; Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France. matthieu.duchmann@aphp.fr.; Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. matthieu.duchmann@aphp.fr.

Publikováno v: Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 918-922. Date of Electronic Publication: 2024 Feb 17.